Daniel P Ikeda is categorized under Internal Medicine Practitioners in Sacramento, CA and active since 2011.
Daniel P Ikeda was established in 2011, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Internal Medicine Practitioners business, which does work in the B2C market, and is classified as a Internal Medicine Practitioners, under code number 621111 by the NAICS.
If you are seeking more information, feel free to contact Daniel Ikeda at the company’s single location by writing to 77 Cadillac Drive # 210, Sacramento, California CA 95825 or by phoning (916) 325-1040. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Daniel P Ikeda |
| Contact Person: | Daniel Ikeda |
| Address: | 77 Cadillac Drive # 210, Sacramento, California 95825 |
| Phone Number: | (916) 325-1040 |
| Website Address: | pmamed.com |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 2011 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Internal Medicine Practitioners |
| SIC Code: | 8011 |
| NAICS Code: | 621111 |
| Share This Business: |
Daniel P Ikeda was started in 2011 to provide professional Internal Medicine Practitioners under the SIC code 8011 and NAICS code 621111. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Daniel Ikeda for inquiries that concern Daniel P Ikeda by calling the company number (916) 325-1040, as your correspondence is most welcome. Additionally, the physical location of the single location of Daniel P Ikeda can be found at the coordinates 38.572882,-121.418544 as well as the street address 77 Cadillac Drive # 210 in Sacramento, California 95825.
For its online presence, you may visit Daniel P Ikeda’s website at pmamed.com and engage with its social media outlets through on Twitter and on Facebook.